HSV-2 Vaccine (AlphaVax)

N/A

Report date: 2026/03/27 16:04:29

Base Information

Drug NameHSV-2 Vaccine (AlphaVax)
Drug Alias Nameherpes simplex virus vaccine (AlphaVax)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHerpes Simplex Virus Type 2 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlphavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlphavax Inc
Inactive CompaniesN/A
Active IndicationsHerpes Simplex Virus Type 2 Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A